• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾血管疾病中肾衰竭的病理生理学

Pathophysiology of renal failure in renovascular disease.

作者信息

Textor S C

机构信息

Department of Medicine, Mayo Clinic, Rochester, MN 55905.

出版信息

Am J Kidney Dis. 1994 Oct;24(4):642-51. doi: 10.1016/s0272-6386(12)80226-5.

DOI:10.1016/s0272-6386(12)80226-5
PMID:7942823
Abstract

Recent attention has focused on renovascular compromise as a cause of chronic renal failure. The sequence by which kidneys functioning near the limits of "critical perfusion pressures" develop parenchymal injury is not well understood. We studied poststenotic renal pressures, glomerular volume, and renal function in conscious rats using an aortic coarct model during antihypertensive therapy with sodium restriction and angiotensin-converting enzyme inhibition over 4 weeks. These were compared with acute reduction of renal pressures using aortic ligation. Both models reduced poststenotic pressures to 50 to 60 mm Hg. Total aortic ligation produced tubular necrosis and glomerular collapse with 40-fold elevated urinary N-acetyl-glucosaminidase excretion. In contrast, angiotensin-converting enzyme inhibition reduced renal blood flow by 30% without evident disruption in tubular function, reflected by low fractional excretion of sodium levels and normal excretion of N-acetyl-glucosaminidase. The glomerular filtration rate and filtration fraction were reduced. These results indicate that gradual reduction of renal perfusion pressure produces functional and morphologic consequences different from those observed with acute ischemic injury. Mechanisms by which chronic renal perfusion deficits produce tissue injury are reviewed and may include disruption of vascular regulation, energy storage molecules, cellular ion gradients, free radical generation, and disruption of cytoskeletal configuration and repair mechanisms. Further study of the pathways of chronic renal parenchymal injury beyond arterial stenosis is essential to achieve rational intervention and revascularization in humans.

摘要

近期,肾血管受损作为慢性肾衰竭的一个病因已受到关注。肾脏在接近“临界灌注压”极限状态下运行时发生实质损伤的具体过程尚不清楚。我们在为期4周的限钠及血管紧张素转换酶抑制降压治疗期间,利用主动脉缩窄模型对清醒大鼠的狭窄后肾压力、肾小球体积和肾功能进行了研究。并将这些结果与通过主动脉结扎急性降低肾压力的情况进行了比较。两种模型均将狭窄后压力降至50至60毫米汞柱。完全主动脉结扎导致肾小管坏死和肾小球塌陷,尿N - 乙酰 - 氨基葡萄糖苷酶排泄升高40倍。相比之下,血管紧张素转换酶抑制使肾血流量减少30%,但肾小管功能无明显破坏,表现为低钠排泄分数水平及N - 乙酰 - 氨基葡萄糖苷酶排泄正常。肾小球滤过率和滤过分数降低。这些结果表明,肾灌注压的逐渐降低所产生的功能和形态学后果与急性缺血性损伤所观察到的不同。本文对慢性肾灌注不足导致组织损伤的机制进行了综述,可能包括血管调节、能量储存分子、细胞离子梯度、自由基生成以及细胞骨架结构和修复机制的破坏。进一步研究动脉狭窄以外的慢性肾实质损伤途径对于实现人类合理的干预和血管重建至关重要。

相似文献

1
Pathophysiology of renal failure in renovascular disease.肾血管疾病中肾衰竭的病理生理学
Am J Kidney Dis. 1994 Oct;24(4):642-51. doi: 10.1016/s0272-6386(12)80226-5.
2
Ischemic nephropathy/azotemic renovascular disease.缺血性肾病/氮质血症性肾血管疾病
Semin Nephrol. 2000 Sep;20(5):489-502.
3
Regulation of renal hemodynamics and glomerular filtration in patients with renovascular hypertension during converting enzyme inhibition with captopril.肾血管性高血压患者在使用卡托普利进行转换酶抑制治疗期间的肾血流动力学和肾小球滤过的调节
Am J Med. 1984 May 31;76(5B):29-37. doi: 10.1016/0002-9343(84)90880-5.
4
Angiotensin-converting enzyme inhibition in renal disease; contrasting effects on renal function in renal artery stenosis and progressive renal injury.肾脏疾病中的血管紧张素转换酶抑制作用;对肾动脉狭窄和进行性肾损伤时肾功能的不同影响。
J Hum Hypertens. 1989 Jun;3 Suppl 1:107-15.
5
Effects of converting enzyme inhibition on split renal function in renovascular hypertension.转换酶抑制对肾血管性高血压患者分肾功能的影响。
Hypertension. 1986 May;8(5):415-21. doi: 10.1161/01.hyp.8.5.415.
6
Impaired renal blood flow and cortical pressure autoregulation in contralateral kidneys of Goldblatt hypertensive rats.戈德布拉特高血压大鼠对侧肾脏肾血流量受损及皮质压力自动调节功能异常。
Hypertension. 1981 Jan-Feb;3(1):67-74. doi: 10.1161/01.hyp.3.1.67.
7
Renal artery stenosis: a common, treatable cause of renal failure?肾动脉狭窄:肾衰竭常见的可治疗病因?
Annu Rev Med. 2001;52:421-42. doi: 10.1146/annurev.med.52.1.421.
8
Angiotensin-converting enzyme inhibition: renal aspect.血管紧张素转换酶抑制:肾脏方面。
J Cardiovasc Pharmacol. 1985;7 Suppl 1:S40-4. doi: 10.1097/00005344-198507001-00009.
9
[Predictors of successful renal artery revascularization in atherosclerotic renovascular disease].[动脉粥样硬化性肾血管疾病中肾动脉血管重建成功的预测因素]
Pol Merkur Lekarski. 2005 Aug;19(110):206-10.
10
Distinct renal injury in early atherosclerosis and renovascular disease.早期动脉粥样硬化和肾血管疾病中的不同肾损伤。
Circulation. 2002 Aug 27;106(9):1165-71. doi: 10.1161/01.cir.0000027105.02327.48.

引用本文的文献

1
Risk of Worsening Renal Function Following Repeated Exposures to Contrast Media During Percutaneous Coronary Interventions.经皮冠状动脉介入治疗中反复接触对比剂后肾功能恶化的风险。
J Am Heart Assoc. 2021 Sep 21;10(18):e021473. doi: 10.1161/JAHA.121.021473. Epub 2021 Sep 17.
2
Genetic deficiency of Smad3 protects the kidneys from atrophy and interstitial fibrosis in 2K1C hypertension.Smad3 基因缺失可保护肾脏免于 2K1C 高血压引起的萎缩和间质纤维化。
Am J Physiol Renal Physiol. 2012 Jun 1;302(11):F1455-64. doi: 10.1152/ajprenal.00645.2011. Epub 2012 Feb 29.
3
Renal Artery Stenosis.
肾动脉狭窄
Curr Treat Options Cardiovasc Med. 1999 Jun;1(1):55-62. doi: 10.1007/s11936-999-0007-7.
4
Atherosclerotic renal artery stenosis: from diagnosis to treatment.动脉粥样硬化性肾动脉狭窄:从诊断到治疗
Postgrad Med J. 1999 Sep;75(887):527-36. doi: 10.1136/pgmj.75.887.527.
5
Atherosclerotic stenosis of the renal arteries. Indications for intervention.肾动脉粥样硬化性狭窄。干预指征。
Tex Heart Inst J. 1998;25(1):34-9.